Independent public reference library

Ageing biology, biomarkers, interventions, and research literacy.

Kidney Regeneration After Acute Injury

Key Takeaways

Acute kidney injury describes a rapid decline in kidney function arising in varied settings, including reduced blood flow, sepsis, toxins, and obstruction. Because these insults differ, “kidney regeneration” is not one uniform event. The best-characterized response is repair of injured tubules, particularly the proximal tubule, while recovery of vessels, interstitium, and filtration function can follow different trajectories. [5] [10]

Who This Is Useful For

This page is useful for readers comparing regeneration with repair, interpreting reports of kidney “recovery,” or trying to understand why apparently resolved acute injury can still be associated with later chronic kidney disease.

What Counts as Kidney Regeneration?

In acute tubular injury, regeneration usually refers to replacement of lost epithelial cells and restoration of a continuous, polarized tubule lining. Surviving cells temporarily reduce expression of mature transport programs, spread over exposed basement membrane, proliferate, and later redifferentiate. This is tissue repair within existing nephrons; it is not evidence that adult humans routinely create whole new nephrons. [1] [2] [5]

Functional recovery is a related but distinct outcome. Serum creatinine and urine output reflect whole-kidney filtration and excretion, so their improvement cannot by itself show which cell types were restored or whether microscopic fibrosis and capillary loss remain. Animal studies have directly demonstrated that fibrosis, microvascular density, and filtration can diverge during recovery. [9] [11]

Repair Outcomes at a Glance

Repair Domain What Can Recover Important Limit Evidence Base
Tubular epithelium Surviving proximal-tubule cells can proliferate and restore epithelial continuity Lineage evidence is principally from mouse ischemia-reperfusion models Mouse lineage tracing [1] [2]
Cell state Injury-associated transcriptional programs can resolve as cells redifferentiate A subset of cells can persist in failed-repair states Mouse single-nucleus sequencing [4]
Microvasculature Endothelial integrity and pericyte support can be preserved or partly restored Pericyte detachment and capillary rarefaction can persist after injury Human transplant biopsies and mouse experiments [8] [9]
Whole-kidney function Filtration markers and urine output may return toward baseline Clinical recovery does not exclude residual damage or increased long-term risk Human cohort meta-analysis [11]

Which Cells Rebuild Injured Tubules?

Two mouse studies addressed whether a fixed population of intratubular stem or progenitor cells supplies new proximal-tubule epithelium. Sequential labelling showed that cell division after injury was broadly distributed rather than repeatedly concentrated in a specialized progenitor population. Genetic lineage tracing then showed that labelled, differentiated proximal-tubule cells expanded after injury without dilution by an unlabelled cell source. Together, these experiments support self-duplication by surviving epithelial cells as a major repair mechanism in those models. [1] [2]

These surviving cells are not unchanged copies of their pre-injury state. They transiently express injury, developmental, and putative progenitor markers while losing some mature transport features. FOXM1-dependent cell-cycle activity contributes to the proliferative phase in mouse ischemic injury. The resulting plasticity is therefore better described as an injury-induced cell state than as proof of a permanently resident, universally active kidney stem-cell pool. [2] [3]

Successful Repair and Failed Repair

Single-nucleus sequencing across a mouse injury time course identified both proliferating repair cells and a distinct proximal-tubule state that persisted after the acute phase. These failed-repair cells retained reduced differentiation markers and expressed inflammatory and profibrotic programs. Related signatures were detectable in other injury datasets and increased over time in human kidney-allograft data, but the cell state was defined most directly in mice. [4]

A later multimodal study described a related distinction involving SOX9. Mouse epithelial lineages that switched SOX9 off regained epithelial organization without fibrosis, whereas cells with sustained SOX9 and CDH6 expression remained poorly polarized and activated WNT signalling to adjacent fibroblasts. Similar marker combinations were observed in human renal allografts. This connects a persistent epithelial repair attempt with local fibroblast activation, while stopping short of showing that one pathway explains every form of post-injury fibrosis. [6]

Cell-cycle arrest provides another experimentally supported route to maladaptive repair. In mouse ischemic, toxic, and obstructive injury models, accumulation of proximal-tubule cells in G2/M was associated with JNK activation, profibrotic cytokine production, and later fibrosis. This is causal evidence within those models, not a universal clinical test for failed repair in people. [7]

Repair Is a Multicellular Process

Macrophages can have different roles over the course of injury. In mouse ischemia-reperfusion injury, inflammatory macrophage markers predominated early, while later macrophage populations expressed a different program associated with tubular proliferation and repair. Experimental depletion at different times produced different effects, showing that “inflammation” is not a single uniformly harmful or beneficial component of regeneration. [5]

Vascular support also matters. Human transplant biopsies taken after reperfusion showed more severe peritubular endothelial injury in grafts that subsequently had sustained rather than rapid functional impairment. In mice, acute injury increased separation of pericytes from endothelial cells, and selective pericyte loss was sufficient to cause enduring capillary rarefaction and focal tubular injury. These findings link epithelial recovery to the condition of the surrounding microvasculature. [8] [9]

What Human Evidence Can Show

Direct lineage tracing is not available in human kidneys, so human studies use biopsies, clinical trajectories, and cells shed into urine. Single-cell sequencing of urinary cells from 32 people with acute kidney injury found tubular-cell programs related to oxidative stress, inflammation, and tissue rearrangement; the authors compared these patterns with human post-mortem biopsies and mouse data. This provides evidence that several injury and repair states occur in people, but urinary cells are a selected sample of cells released from the kidney rather than a complete map of the organ. [10]

Long-term clinical studies also show why short-term recovery should be interpreted cautiously. A meta-analysis of 13 cohort studies found that people with acute kidney injury had higher subsequent risks of chronic kidney disease, kidney failure, and death than comparison groups without acute kidney injury. Because these were observational cohorts with differences in baseline illness and kidney health, the estimates establish association and graded risk, not a single cellular mechanism or an inevitable outcome for each patient. [11]

Ageing and Regenerative Reserve

Ageing may narrow the margin between adaptive and maladaptive repair, but mechanistic evidence is largely preclinical. In a folic-acid injury model, older mice had greater tubular damage, inflammatory infiltration, cell-death signalling, DNA-damage markers, and expression of senescence-associated factors than younger mice at 48 hours. The experiment demonstrates an age effect in that toxic-injury model; it does not define a human age threshold at which kidney repair fails. [12]

Evidence Quality and Interpretation

Confidence is strong that surviving tubular epithelial cells can proliferate after acute injury and that epithelial redifferentiation is central to structural repair. The strongest cell-origin evidence comes from genetic lineage tracing in mice, supported by time-resolved transcriptional studies. [1] [2] [4]

Confidence is also strong that incomplete repair can involve persistent epithelial stress, inflammation, microvascular disruption, and fibroblast activation. Their relative contribution varies with injury type, severity, timing, and model, and a rise or fall in one component does not summarize the entire repair process. [4] [6] [9]

Confidence is lower when a pathway discovered in controlled mouse ischemia or toxin experiments is used to predict regeneration in heterogeneous human acute kidney injury. Human sampling is limited, causes often overlap, and filtration measurements cannot directly identify cell lineage or tissue architecture. [10] [11]

What This Does Not Mean

Practical Interpretation Examples

Related Reading

Summary

Kidney recovery after acute injury combines epithelial regeneration with immune, vascular, and stromal remodelling. Surviving tubular cells can enter a temporary plastic and proliferative state, then redifferentiate to rebuild damaged tubules. When this sequence remains incomplete, persistent epithelial stress, capillary rarefaction, inflammation, and fibroblast activation can connect an acute event to chronic damage. The kidney therefore has substantial repair capacity, but functional recovery, structural restoration, and long-term risk are distinct outcomes. [2] [4] [9] [11]

References

  1. Humphreys, B. D., Czerniak, S., DiRocco, D. P., et al. (2011). Repair of injured proximal tubule does not involve specialized progenitors. Proceedings of the National Academy of Sciences. https://pubmed.ncbi.nlm.nih.gov/21576461/
  2. Kusaba, T., Lalli, M., Kramann, R., et al. (2014). Differentiated kidney epithelial cells repair injured proximal tubule. Proceedings of the National Academy of Sciences. https://pmc.ncbi.nlm.nih.gov/articles/PMC3910580/
  3. Chang-Panesso, M., Kadyrov, F. F., Lalli, M., et al. (2019). FOXM1 drives proximal tubule proliferation during repair from acute ischemic kidney injury. Journal of Clinical Investigation. https://www.jci.org/articles/view/125519
  4. Kirita, Y., Wu, H., Uchimura, K., et al. (2020). Cell profiling of mouse acute kidney injury reveals conserved cellular responses to injury. Proceedings of the National Academy of Sciences. https://pmc.ncbi.nlm.nih.gov/articles/PMC7355049/
  5. Lee, S., Huen, S., Nishio, H., et al. (2011). Distinct macrophage phenotypes contribute to kidney injury and repair. Journal of the American Society of Nephrology. https://pmc.ncbi.nlm.nih.gov/articles/PMC3029904/
  6. Aggarwal, S., Grange, J., Mugisho, O. O., et al. (2024). SOX9 switch links regeneration to fibrosis at the single-cell level in mammalian kidneys. Science. https://pubmed.ncbi.nlm.nih.gov/38386758/
  7. Yang, L., Besschetnova, T. Y., Brooks, C. R., et al. (2010). Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury. Nature Medicine. https://pubmed.ncbi.nlm.nih.gov/20436483/
  8. Kwon, O., Hong, S.-M., Sutton, T. A., & Temm, C. J. (2008). Preservation of peritubular capillary endothelial integrity and increasing pericytes may be critical to recovery from postischemic acute kidney injury. American Journal of Physiology - Renal Physiology. https://pubmed.ncbi.nlm.nih.gov/18562634/
  9. Kramann, R., Wongboonsin, J., Chang-Panesso, M., et al. (2017). Gli1-positive pericyte loss induces capillary rarefaction and proximal tubular injury. Journal of the American Society of Nephrology. https://pubmed.ncbi.nlm.nih.gov/27624490/
  10. Klocke, J., Kim, S. J., Skopnik, C. M., et al. (2022). Urinary single-cell sequencing captures kidney injury and repair processes in human acute kidney injury. Kidney International. https://pubmed.ncbi.nlm.nih.gov/36049643/
  11. Coca, S. G., Singanamala, S., & Parikh, C. R. (2012). Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis. Kidney International. https://pmc.ncbi.nlm.nih.gov/articles/PMC3788581/
  12. Marquez-Exposito, L., Tejedor-Santamaria, L., Valentijn, F. A., et al. (2021). Acute kidney injury is aggravated in aged mice by the exacerbation of proinflammatory processes. Frontiers in Pharmacology. https://pubmed.ncbi.nlm.nih.gov/34239439/
Educational Disclaimer

This content is provided for educational purposes only and does not constitute medical advice.